NanoViricides, Inc. Files Quarterly Report - Reports A Strong Cash Position Sufficient For Clinical Trials Of Its First Two Drug Candidates

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), has filed its quarterly report with the Securities and Exchange Commission on Thursday, May 15th, in a timely fashion. The submission can be downloaded from the SEC website at http://www.sec.gov/Archives/edgar/data/1379006/000114420414031119/v378344_10q.htm.

Help employers find you! Check out all the jobs and post your resume.

Back to news